Together, we can find a cure.

Kidney Cancer Research Summit

#KCRS20

Together, we can find a cure.

Kidney Cancer Research Summit

#KCRS20

“It’s one of the most exciting things I’ve ever participated in. We’re bringing together clinicians, physician scientists, and bench scientists to talk about kidney cancer research. The goal is to invigorate the science and spur breakthroughs.”

– Dr. Hans Hammers, UTSW

Welcome to #KCRS20!

Video Content Is Up! 

KidneyCAN is proud to have held the 2nd annual Kidney Cancer Research Summit, a meeting focused on basic and translational science, as well as cutting edge translational research, on October 22-23, 2020. Over 850 registrants from 43 countries around the globe joined us for these presentations. This work is fueled by the funding from the Department of Defense CDMRP – KCRP.

Thank you!

William Kaelin presents at #KCRS20
#KCRS20 Attendees from All Over the Globe
#KCRS20 Session Two Panelists
The entire KidneyCAN team wants to say THANK YOU!

Thank you to our Co-Chairs, Steering Committee, speakers and panelists for your time, guidance, enthusiasm, and research.

Thank you to our wonderful audience! 

  • 825 registrants
  • 43 countries from across the globe
  • 39 U.S. states
The questions and conversations on line between researchers and doctors brought the meeting alive!

We want to convey our sincere appreciation to our sponsors for making #KCRS20 possible. The support of companies large and small working to make new treatments available brings true hope for patients. Thank you to our industry research partners!

If you did not have time to visit the #KCRS20 Sponsors during the meeting, we hope you will visit their virtual exhibits, where they’ve provided many free resources and downloads for doctors.

We value your opinions, feedback and constructive ideas. Please take a few moments to answer our short survey or share your thoughts with us directly by e-mail here.

Until next year, warmest regards,

Susan Poteat, KidneyCAN Medical Science Liaison

Bryan Lewis, KidneyCAN President

KidneyCAN presents #KCRS20

Thursday Topics: Keynote, Sessions 1 & 2, Discussion

Welcome and Introductions


Bryan Lewis, KidneyCAN President
Toni Choueiri, KCRS Co-Chair, Dana-Farber Cancer Institute
Hans Hammers, KCRS Co-Chair, University of Texas Southwestern

Keynote Presentation: “Can Studies of the VHL Gene Get Us to Curative Combination Therapies for Kidney Cancer?”


Dr. William Kaelin, Jr., Nobel Laureate
Harvard/Dana-Farber Cancer Institute

Breakout Discussion | Variant RCC: Where Are We Now, and Where Do We Go?

Friday Topics: Sessions 3 & 4

On-Demand Content

View pre-recorded sessions here!

The Next Frontier: New Molecular Targets for Kidney Cancer
“Profilin 1 as a Novel Target in Patients with RCC”
Partha Roy, University of Pittsburgh
Novel Models for Kidney Cancer Research
“Unlocking the Human Relevance of a New Genetic Papillary RCC Mouse Model”
Richard Link, Baylor College of Medicine

“Modeling Spatial Ecology in Clear Cell Renal Cell Carcinoma Model: A Novel Tool to Support Drug Sequencing Decisions”
Brandon Manley, H. Lee Moffitt Cancer Center

“Kidney Cancer (DFCI) Model”
Laura Stransky, Dana Farber Cancer Institute

Germline Genetics and Implications
“Biological Determinants of Kidney Cancer Health Disparities”
Khadijah Mitchell, Lafayette College
Variant Kidney Cancer Histologies: Characterization and Therapeutic Targeting
“Chromophobe RCC: New Concepts in Pathogenesis”
Elizabeth Henske, Brigham & Women’s Hospital

“Defining the Role of Beta-Catenin Activation in Wilms Tumor”
Keri Drake, University of Texas Southwestern

“Molecular Characterization and Therapeutic Targeting of TFE3 Fusion Kidney Cancers”
Srinivas Viswanathan, Dana Farber Cancer Institute

#KCRS20 Partners

The second annual Kidney Cancer Research Summit is made possible through the generous contributions of our sponsors:

BMS | KCRS20 Sponsor
Nektar | KCRS Sponsor

Ralph & Brenda Knapp

The Kidney Cancer Research Summit is also funded by KidneyCAN's grassroots supporters, a nationwide network of kidney cancer patients, caregivers, and family members who are committed to finding a cure.

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program).

KidneyCAN Platinum Guidestar Seal

KidneyCAN is a registered 501(c)(3) nonprofit grassroots organization dedicated to funding and finding a cure for kidney cancer.

Contact KidneyCAN

KidneyCAN, 8327 Germantown Avenue, Philadelphia, PA 19118